scispace - formally typeset
M

Masahiro Hiratsuka

Researcher at Osaka University

Publications -  57
Citations -  2317

Masahiro Hiratsuka is an academic researcher from Osaka University. The author has contributed to research in topics: Cancer & Survival rate. The author has an hindex of 15, co-authored 56 publications receiving 2163 citations.

Papers
More filters
Journal ArticleDOI

D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.

TL;DR: Treatment with D2 lymphadenectomy plus PAND does not improve the survival rate in curable gastric cancer, and no significant differences in recurrence-free survival are found.
Journal ArticleDOI

Gastric Cancer Surgery: Morbidity and Mortality Results From a Prospective Randomized Controlled Trial Comparing D2 and Extended Para-Aortic Lymphadenectomy—Japan Clinical Oncology Group Study 9501

TL;DR: Specialized surgeons could safely perform gastrectomy with D2 lymphadenectomy with para-aortic nodal dissection in patients with low operative risks without increasing major surgical complications in this setting.
Journal Article

Expression of N-acetylglucosaminyltransferase V in colorectal cancer correlates with metastasis and poor prognosis.

TL;DR: Direct evidence is shown for the relationship between GnT-V and metastasis in human colorectal cancer and Screening of Gn T-V expression in coloreCTal cancer may provide useful information for prognosis of postoperative patients.
Journal ArticleDOI

Influence of Overweight on Surgical Complications for Gastric Cancer: Results From a Randomized Control Trial Comparing D2 and Extended Para-aortic D3 Lymphadenectomy (JCOG9501)

TL;DR: Surgical complications, operation time, and blood loss were statistically significantly associated with BMI, and logistic regression analysis revealed that overweight directly affected the occurrence of surgical complications even after considering operation time andBlood loss as intermediate factors instead of outcome variables.
Journal ArticleDOI

Expression of carbohydrate antigen sialyl Le(a): a new functional prognostic factor in gastric cancer.

TL;DR: Increased expression of the sLe(a) antigen may serve as a potent prognostic indicator for recurrence in patients with gastric cancer.